Take Control of Your Family’s Cancer Risk with CDKN2A Genetic Testing
When cancer runs in your family, the uncertainty can feel overwhelming. You worry about your children, your siblings, and your own future. Our CDKN2A genetic test provides the clarity you need to make informed decisions about your health and break the cycle of hereditary cancer risk.
Understanding Your CDKN2A Genetic Test
The CDKN2A gene plays a crucial role in protecting your body from cancer development. When this gene contains specific changes (mutations), it significantly increases your risk of developing pancreatic cancer and melanoma. Our advanced Next-Generation Sequencing (NGS) technology examines your DNA with exceptional accuracy to identify these inherited risk factors.
This isn’t just a test – it’s a powerful tool for proactive health management that could save lives in your family.
Who Should Consider CDKN2A Genetic Testing?
This test is particularly important if you or your family members experience:
- Multiple cases of pancreatic cancer in close relatives
- Family history of melanoma, especially at young ages
- Personal diagnosis of pancreatic cancer or melanoma with family history
- Known CDKN2A mutation in your family
- Multiple primary melanomas in one person
- Family members with both pancreatic cancer and melanoma
If you’ve ever wondered “Could this happen to me?” – this test provides the answers you deserve.
Why This Test Matters for Your Family’s Health
Early detection through genetic testing transforms fear into action. Knowing your CDKN2A status enables:
- Personalised Screening: Tailored cancer surveillance based on your actual risk
- Preventive Measures: Lifestyle and medical interventions to reduce cancer risk
- Family Planning: Informed decisions about genetic risk to children
- Peace of Mind: Either way the results go, you’ll have clarity instead of uncertainty
- Early Intervention: The opportunity to detect cancer at its most treatable stages
Understanding Your Test Results
We know waiting for genetic results can be stressful. Our comprehensive approach ensures you receive not just results, but understanding and support:
- Positive Result: We’ll connect you with specialist oncologists and create a personalised surveillance plan
- Negative Result: Peace of mind that you haven’t inherited the family cancer risk
- Uncertain Variant: Expert interpretation and ongoing monitoring recommendations
Our genetic counselling team will walk you through every step, ensuring you feel supported and informed.
Affordable Genetic Testing for South African Families
| Test Option | Regular Price | Special Price | Savings |
|---|---|---|---|
| CDKN2A Genetic Test | ZAR 6,700 | ZAR 2,650 |
Consider this investment against the potential cost of late-stage cancer treatment and the priceless value of early detection.
Test Details & Preparation
- Turnaround Time: 3-4 weeks
- Sample Type: Blood, Extracted DNA, or One drop Blood on FTA Card
- Preparation Required: Clinical history and genetic counselling session to create family pedigree
- Technology: Advanced NGS (Next-Generation Sequencing)
- Specialist: Oncologist-reviewed results
Why Trust Oracle Genomics?
We understand the emotional weight of genetic testing. That’s why we’ve built our service around trust, accuracy, and patient care:
- Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Expert Genetic Counselling: Professional guidance before, during, and after testing
- Advanced Technology: State-of-the-art NGS for unparalleled accuracy
- Medical Expertise: Oncologist-supervised testing and interpretation
- Patient-Centred Care: We treat you like family, because your health matters to us
Take the First Step Toward Cancer Prevention Today
Don’t let family cancer history control your future. Knowledge is power, and early detection through genetic testing could be life-saving for you and your loved ones.
Book your genetic counselling session now and take control of your health destiny.
Limited time special pricing available. Your family’s health is worth investing in.
